38. Gandia P, Idier I and Houin G (2007), “Is once-daily mesalazine equivalent to the currently used twice-daily regimen? A study performed in 30 healthy volunteers”, The Journal of Clinical Pharmacology; 47(3): 334–342
39. Gu G-Z, Xia H-M, Pang Z-Q, Liu Z-Y, Jiang X-G and Chen J (2011). “Determination of sulphasalazine and its main metabolite sulphapyridine and 5-aminosalicylic acid in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study”. Journal of Chromatography B; 879(5): 449–456.
40. Gu GZ, Xia HM, Pang ZQ, Liu ZY, Jiang XG, Chen J (2011) “Determination of sulphasalazine and its main metabolite sulphapyridine and 5-aminosalicylic acid in human plasma by liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study”, J Chromatogr B Analyt Technol Biomed Life Sci. 879 (5-6), 449-56
41. Gupta Vinay K, Gnanarajan G, et al. (2012), "A review article on colonic targeted drug delivery system", The pharma innovation, 1(7, Part A), pp. 14.
42. H. H. Gangurde1, M. A. Chordiya, S. Tamizharasi, and T. Sivakumar (2013), “Statistical Optimization of Mesalamine Coated Pellets for Possible Ileo–cecal Targeting”, Mahidol University Journal of Pharmaceutical Sciences, 40 (2), 25 – 44.
43. Han M., Fang Q.-L., Zhan H.-W., et al. (2009), "In vitro and in vivo evaluation of a novel capsule for colon-specific drug delivery", Journal of pharmaceutical sciences, 98(8), pp. 2626-2635
44. Hauschke D., Steinijans V. et al. (2007), “Bioequivalence studies in drug development methods and applications”, Jonh Wiley & Sons, 1 – 156.
45. He W., Du Q., Cao D.-Y., et al. (2008), "Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats", International journal of pharmaceutics, 348(1-2), pp. 35-45
46. Hussein O. Ammar, Mamdouh M. Ghorab, Linda A. Felton, Shadeed Gad and Aya A. Fouly (2015), “Effect of antiadherents on the physical and drug release properties of acrylic polymeric films”, AAPS PharmSciTech, 17, 682-692.
47. Iman S. Ahmed et al. (2011), "Comparison of in vitro and in vivo performance of a colonic delivery system", International Journal of Pharmaceutics, 409, pp.169-177
Có thể bạn quan tâm!
-
Nghiên Cứu Bào Chế Pellet Mesalamin Bao Giải Phóng Tại Đại Tràng -
Tiêu Chuẩn Cơ Sở Viên Mesalamin Giải Phóng Tại Đại Tràng -
Nghiên cứu bào chế pellet mesalamin giải phóng tại đại tràng - 22 -
Một Số Dữ Liệu Thẩm Định Các Phương Pháp Định Lượng Mesalamin -
Kết Quả Khảo Sát Độ Chính Xác Trung Gian -
Kết Quả Khảo Sát Tính Phù Hợp Của Hệ Thống
Xem toàn bộ 299 trang tài liệu này.
48. Jagan Bahekar, Sailesh Jayantilal Wadher (2019), “Formulation development of colon targeted mesalamine pellets: in vitro-in vivo release study”, International Journal of Applied Pharmaceutics, 11(6), 125 – 132.
49. Jaleh Varshosaz, Jaber Emami, Naser Tavakoli, Mohsen Minaiyan, Nakisa Rahmani, Farid Dorkoosh, Parvin Mahzouni (2012), “Pectin film coated pellets for colon-targeted delivery of budesonide: In-vitro/in-vivo evaluation in induced ulcerative colitis in rat”, Iran J Pharm Res, 11(3), 733 – 45
50. Jenita J., Raj B. (2010), "Formulation and evaluation of compression coated tablets of mesalazine for colon delivery", International Journal of Pharm Tech Research, 2(1), pp. 535-541
51. Juan Qin, Xin Di, Xin Wang and Youping Liu (2014), “Development and validation of an LC-MS/MS method for the determination of mesalazine in beagle dog plasma and its application to a pharmacokinetic study”, Biomedical chromatography, 29 (2), 261-267.
52. Kanchanamala Kanala, Nagiat T. Hwisa, Babu Rao Chandu, Fathi H. Assaleh,
K. Mukkanti, Prakash Katakam and Bala Sekhara Reddy Chally (2014), “Simultaneous quantification of mesalamine in human plasma by LC-MS/MS and its application to a bioequivalence study”, British journal of pharmaceutical research, 4(13), 1568 – 1590.
53. Kumar V., Tiwary A., Kaur G. (2010), "Investigations on chitosan carboxymethyl guar gum complexes interpolymer complexes for colon delivery of fluticasone", International Journal of Drug Delivery, 2(3), pp. 242- 250
54. Leopold Claudia S, Eikeler Dorothee (1998), "Eudragit® E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD)", Journal of drug targeting, 6(2), pp. 85-94
55. M Ramanathan, L Subramanian, Bency Susan Varghese (2018), “Formulation and evaluation of colon targeted matrix tablets of ibuprofen”, Asian Journal of Pharmaceutical Research and Development, 6(2), pp 9-19
56. M. Khotimchenko (2020), “Pectin polymers for colon-targeted antitumor drug delivery”, International Journal of Biological Macromolecules, 158, 1110 – 1124.
57. Mahmoud H. Othman , Gamal M. Zayed , Usama F. Ali & Ahmed A. H. Abdellatif (2020), “Colon-specific tablets containing 5-fluorouracid microsponges for colon cancer targeting”, Drug development and Industrial Pharmacy, 1 – 8.
58. Malik K., Goswami L., Kothiyal P., et al. (2012), "A review on colon targeting drug delivery system: Novel approaches, anatomy and evaluation", The Pharma Innovation, 1(9, Part A), p. 1.
59. Mario-Livio Jeličić, Edvin Brusač, Daniela Amidžić Klarić, Biljana Nigović, Sabina Keser, and Ana Mornar (2020), “Physicochemical compatibility investigation of mesalazine and folic acid using chromatographic and thermoanalytical techniques”, Pharmaceuticals, 13(8): 187.
60. Markus W. Rudolph, Sandra Klein, Thomas E. Beckert, Hans-Ulrich Petereit, Jennifer B. Dressman (2001), “A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis”, Eur J Pharm Biopharm, 51, 183- 190.
61. Maroni A., Del Curto M. D., et al. (2009), "Feasibility, stability and release performance of a time-dependent insulin delivery system intended for oral colon release", Eur J Pharm Biopharm, 72(1), pp. 246-251.
62. Md. Akhlaquer Rahman, Alka Ahuja, S. Baboota, Bhavna, Vikas Bali, Nitin Saigal and Javed Ali (2009), “Recent advances in pelletization technique for oral drug delivery: a review”, Current Drug Delivery, 6, 122 – 129.
63. Meixia Xu, Minjie Sun, Hongzhi Qiao, Qineng Ping, Eltayeb Suliman Elamin (2014), “Preparation and evaluation of colon adhesive pellets of 5- aminosalicylic acid”, Int Pharrm, 468 (1-2), 165-171.
64. Mingxiao Cui, Min Zhang, Kehai Liu (2021), “Colon-targeted drug delivery of polysaccharide-based nanocarriers for synergistic treatment of inflammatory bowel disease: A review”, Carbohydrate Polymers, 272.
65. Minh N.U. Nguyen, Phuong H.L. Tran, Thao T.D. Tran (2019), “A single- layer film coating for colon-targeted oral delivery”, International Journal of Pharmaceutics, 559(2019), pp 402-409
66. Mohammad F. Bayan, Rana F. Bayan (2020), “Recent advances in mesalamine colonic delivery systems”, Future Journal of Pharmaceutical Sciences, 6(43), 1- 7.
67. Mohammed Maniruzzaman, Joshua S. Boateng, Martin J. Snowden and Dennis Douroumis (2012), “A Review of Hot-Melt Extrusion: Process Technology to Pharmaceutical Products”, ISRN Pharm, 1-9.
68. Mohd Abdul Hadi1*, NG Raghavendra Rao and A Srinivasa Rao (2014), “Formulation and Evaluation of pH-Responsive Mini-Tablets for Ileo-Colonic Targeted Drug Delivery”, Tropical Journal of Pharmaceutical Research, 13 (7), 1021-1029
69. Monica C. Chuong, J. Mark Christensen, James W. Ayres (2008), “New dissolution method for mesalamine tablets and capsules” Dissolution Technologies, 15(3).
70. Murtada A.Oshi, Muhammad Naeem, Junhwan Bae, Jihyun Kim, Juho Lee, Nurhasni Hasan, Wooseong Kim, Eunok Im, Yunjin Jung, Jin-Wook Yoo (2018), “Colon-targeted dexamethasone microcrystals with pH-sensitive chitosan/alginate/Eudragit S multilayers for the treatment of inflammatory bowel disease”, Carbohydrate Polymers, pp 434 – 442
71. Nguyen Thach Tung, Canh Hung Nguyen, Van Duong Nguyen, Thi Hong Thuy Nguyen, Van Lam Nguyen, Cao Son Tran, Thi Minh Hue Pham (2020), “Formulation and in vivo imaging evaluation of colonic targeting tablets
prepared by a simple dry powder coating technique”, Journal of Pharmaceutical Investigation, 50, pp. 383-398.
72. Nobilis M, Vybiralova Z, Sladkova K, Lisa M, Holcapek M, Kvetina J (2006) “High-performance liquid-chromatographic determination of 5- aminosalicylic acid and its metabolites in blood plasma”, J Chromatogr A, 1119 (1-2), 299-308.
73. Nugent, Rampton, Evans, et al (2001), “Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs”, Gut, pp 571 – 577.
74. OzlemCoban, ZeynepAytac, Zehra IremYildiz, TamerUyar (2021), “Colon targeted delivery of niclosamide from β-cyclodextrin inclusion complex incorporated electrospun Eudragit® L100 nanofibers”, Colloids and Surfaces B: Biointerfaces, pp 1-18
75. Palumbo G, Bacchi S, Primavera L, Palumbo P and Carlucci G (2005). “A validated HPLC method with electrochemical detection for simultaneous assay of 5-aminosalicylic acid and its metabolite in human plasma”. Biomedical Chromatography; 19(5): 350–354
76. Pastorini E, Locatelli M, Simoni P, Roda G, Roda E and Roda A (2008). “Development and validation of a HPLC-ESI-MS/MS method for the determination of 5-aminosalicylic acid and its major metabolite N-acetyl-5- aminosalicylic acid in human plasma”. Journal of Chromatography B; 872(1): 99–106.
77. Patel J.K., Patel N.V., Shah S.H. (2009), "Formulation and in-Vitro evaluation of mesalamine matrix tablets using chitosan for colonic drug delivery", Journal of Pharmacy Research, 2(7), pp. 1319-1323.
78. Patrycja Wojciechowska (2012), "The Effect of Concentration and Type of Plasticizer on the Mechanical Properties of Cellulose Acetate Butyrate Organic-Inorganic Hybrids", Recent Advances in Plasticizers, pp. 142-164
79. Raditya Iswandana, Kurnia Sari Setio Putri, Fitri Rina Wulandari, Ghaathy Najuda, Santi Purna Sari, Joshita Djajadisastra (2018), “Preparation of
Calcium Alginate-Tetrandrine beads using ionic gelation method as colon- targeted dosage form”, Journal of Applied Pharmaceutical Science, 8(05), 068
– 074
80. Reinout C. A. Schellekens, Jan H. Baltink, Ellen M. Woesthuis, Frans Stellaard, Jos G. W. Kosterink, Herman J. Woerdenbag, and Henderik W. Frijlink (2012), “Film coated tablets (ColoPulse technology) for targeted delivery in the lower intestinal tract: Influence of the core composition on release characteristics”, Pharmaceutical Development and Technology, 17(1), 40 – 47.
81. Rex N. Broghen, Eugene M. Sorkin (1989), “Mesalamin. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in chronic inflammatory bowel disease”, ADIS Pres Limited, 38(4), pp 500- 523.
82. Rita K. Palsmeier, Donna M. Radzik, and Craig E. Lunte (1992), “Investigation of the degradation mechanism of 5-aminosalicylic acid in aqueous solution”, Pharmaceutical Research, 9(7), 933-8.
83. S. J. Kshirsagar, M. R. Bhalekar, N. S. Shewale, V. P. Godbole, P. K. Jagdale & S.K. Mohapatra (2011), “Development of enzyme-controlled colonic drug delivery using amylose and hydroxypropyl methylcellulose: Optimization by factorial design”, Drug delivery, 18 (6), 385 – 393.
84. S. P. Sawarkar1, S. G. Deshpande, A. N. Bajaj, P. S. Soni, P. Pandit, V. S. Nikam (2019), “Potential of low molecular weight natural polysaccharides for colon targeted formulation and its evaluation in human by gamma scintigraphy”, Journal of Pharmaceutical Investigation, 50(2)
85. Sajeev Chandran, Kango Surbhi Sanjay and Laila Fatima Ali Asghar (2009), “Microspheres with pH modulated release: Design and characterization of formulation variables for colonic delivery”, Journal of Microencapsulation, 26(5), 420 – 431.
86. Samar A Afifi, Walaa M Mandour, Kadria A Elkhodairy (2015), “Optimization of a novel oral colon delivery system of Indomethacin using
full factorial design”, Tropical Journal of Pharmaceutical Research, 14(5), 761 – 768.
87. Sanaz Mehdi-alamdarlou1, Negin Mozafari1, Saeid Daneshamouz1, Hajar Ashraf (2022), “Preparation and in vitro evaluation of controlled release granules of mesalazine for colon targeted drug delivery system”, Trends in Pharmaceutical Sciences, 8(1), pp 37-42
88. Sarah Sulaiman , Pavel Gershkovich , Caroline L. Hoad , Matthew Calladine
, Robin C. Spiller, Snow Stolnik and Luca Marciani (2022), “Application of In vivo MRI imaging to track a coated capsule and its disintegration in the gastrointestinal tract in human volunteers”, Pharmaceutics, 14(2): 270.
89. Sateesh Kumar Vemula and Vijaya Kumar Bontha (2013), “Colon targeted guar gum compression coated tablets of flurbiprofen: Formulation, development, and pharmacokinetics”, Hindawi Publishing Corporation, 1 – 8.
90. Satinder Kakar, Deepa Batra, Ramandeep Singh (2013), “Preparation and evaluation of magnetic microspheres of mesalamine (5-aminosalicylic acid) for colon drug delivery”, Journal of Acute Disease, 2(3), pp 226-231
91. Schiller C, Fröhlich C‐P, et al. (2005), "Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging", Alimentary pharmacology & therapeutics, 22(10), pp. 971-979.
92. Siew L. F., Basit A. W., Newton J. M. (2000), " New targeted-colon delivery system: in vitro and in vivo evaluation using X-ray imaging ", AAPS Pharm Sci Tech, 1(3), pp. 53-61
93. Singh A, Mandal U, Narang R. (2021), “Development of cellulose acetate phthalate coated pectin microparticles loaded with mesalamine and saccharomyces boulardii intended for specific colonic drug delivery”, Journal of Advanced Scientific Research, 12(1), 225-235.
94. Sivadasanpillai Harikrishnan (2019), “Diet, the gut microbiome and heart failure”, Card Fail Rev, 5(2), 119 – 122
95. Sridevi Rângnathan, Emily M. Smith, Jennifer D. Foulke-Abel, Eileen M. Barry (2020), “Research in a time of enteroids and organoids: how the human gut model has transformed the study of enteric bacterial pathogens”, Gut Microbes, 12:1.
96. Srini Tenjarla (2015), “Dissolution of commercially available mesalamine formulations at various pH levels”, Short communication, 15, 211 - 215.
97. Susan Hua (2020), “ Advances in oral delivery for regional targeting in the gastrointestinal tract – Influence of physiological, pathophysiological and pharmaceutical factors”, Frontiers in Pharmacology, 11, 1 – 22.
98. Thomas G. Barclay, Candace Minhthu Day, Nikolai Petrovsky, SanjayGarg (2019), “Review of polysaccharide particle-based functional drug delivery”, Carbohydrate Polymers, 221, 94 – 112.
99. Ursula M. S., Hull T. L. (2011), “The ASCRS Textbook of Colon and Rectal Surgery”, Springer Science and Business Media, pp.23-39
100. USP 41, pp 2598 – 2600
101. USP 41, pp 5748 – 5749
102. Vandana Thakur, Amandeep Singh, Nabin Joshi, Neeraj Mishra (2019), “Spray dried formulation of mesalamine embedded with probiotic biomass for the treatment of ulcerative colitis: in-vitro and in-vivo studies”, Drug Development and Industrial Pharmacy, 45 (11), 1807 – 1820.
103. Veerpal Kaur, Amit K. Goyal, Goutam Ghosh, Sudam Chandra Si, Goutam Rath (2020), “Development and characterization of pellets for targeted delivery of 5-fluorouracil and phytic acid for treatment of colon cancer in Wistar rat”, Heliyon, 6 (1).
104. Vikas Kumar, A.K.Tiwary, Gurpreet Kaur (2010), “Investigations on chitosan-carboxymethyl guar gum complexes interpolymer complexes for colon delivery of fluticasone”, International Journal of Drug Delivery, 2, pp. 242-250